NSPR InspireMD, Inc.

NASDAQ
$0.98

InspireMD, Inc. (NSPR) is expected to report earnings on November 13, 2026, before the market open. The consensus earnings estimate is a loss of $0.17 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +15.6% since its last earnings release on August 14, 2026.

InspireMD Beat Consensus Estimates
Earnings Date
3rd Quarter, Sep 2026
Nov 13
Friday · Before Open
Earnings Whisper
-
vs ($0.17)
Rev est $999
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $0.93

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About InspireMD, Inc.

InspireMD Inc together with its subsidiaries, is a medical device company focusing on the development and commercialization of its proprietary stent platform technology, MGuard™.

Sector

Healthcare

Industry

Medical Instruments/Supply